The growth of the epigenetics market is expected to be driven by the decrease in the cost of sequencing, the global increase in the application of next-generation sequencing, and the advancement of the products. However, there are significant challenges restraining the market growth, such as the high-cost epigenetics instruments and dearth of skilled professionals in epigenetic research. Epigenetic mechanisms are being linked to a growing number of chronic diseases and disorders, including cardiovascular diseases, autoimmune diseases, and neurodegenerative disorders, as well as environmental cues and nutrition, which have a significant impact on epigenetic processes such as DNA methylation, histone modification, and non-coding RNA.
Healthcare experts have found the Epigenetics Market to be one of the highest booming markets, and the global market is predicted to grow at a CAGR of 17.11% during the forecast period 2021-2031.
The epigenetics market is an emerging market with huge growth potential. Recent technological advancements are facilitating the adoption of the technology at a rapid pace. Epigenetic alterations can be maintained from cell to cell as cells divide and can be inherited through the generations. Moreover, epigenetic changes are required for normal development and health, and they can also be responsible for some disease states. Disturbing any of the three marks that contribute to epigenetic modification can cause abnormal activation or silencing of genes. In addition, the market of epigenetics is rising due to technological advancements in products offered by the companies.
Request Free Sample - Click Here
Competitive Landscape
The growth of this market can be majorly attributed to the presence of well-established guidelines regarding epigenetics, presence of established companies undertaking key business strategies, rising number of cancer cases, and increasing adoption of products based on advanced molecular technologies by the pharmaceutical and biotechnological companies, among others. Further, increasing focus on research pertaining to the epigenetics biomarkers such as DNA, histones, and non-coding RNA is also expected to support the growth of the epigenetics market during the forecast period, 2021-2031. The growth of other technologies, such as next-generation sequencing and whole genome sequencing, can be attributed to the increased clinical research to understand the involvement of molecular pathology in the diagnosis and prognosis of genetic disorders. Based on region, North America holds the largest share in the market, owing to improved healthcare infrastructure, rise in per capita income, and improvised reimbursement policies in the region. However, the Asia-Pacific region is anticipated to grow at the fastest CAGR during the forecast period 2021-2031.
Key factors driving growth in Cell Sorting Market - Factors such as technological advancements in cell sorters, rising funding and investments for development of technologically advanced cell sorters, and growing adoption of cell sorting techniques in research activities are driving the growth of global Cell Sorting Market.
Cell Sorting Market by Technology (FACS-based Droplet Sorting, MACS, Microfluidics), Product (Cell Sorters, Reagents, Consumables), Application (Research, Clinical), End User (Research Institutes, Biopharma Companies, Medical Schools) How will the Cell Sorting Industry grow in coming years?
A cell sorter separates the target cell population based on their intracellular or extracellular properties (such as protein or enzyme expression; cell size and shape; and presence of specific biomarkers).
Product manufacturer involved in cell sorting market are focusing on new product development as their key growth strategy, to maintain their position in the market and strengthen their revenue base.
Companies also aim to differentiate themselves in the highly competitive market by expanding their product portfolios in accordance with industry trends and client needs.
Currently, leading market players are focusing on entering new markets by launching technologically advanced and innovative products in both developed as well as emerging markets.
